Olanzapine Treated Adolescents With Schizophrenia or Bipolar I Disorder

Clinical trial NCT00113594 · COMPLETED

Trial details

NCT number: NCT00113594
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Schizophrenia Bipolar Disorder

Start date: 2005-06-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.